Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin-A treatment
- PMID: 77947
- DOI: 10.1016/s0140-6736(78)90970-4
Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin-A treatment
Abstract
The fungal metabolite cyclosporin A has been administered daily at 25 mg/kg to nephrectomised rabbit recipients of a single renal allograft. After only 4 weeks of daily administration, rejection was prevented for long periods without the need for other immunosuppressive therapy. Renal function has been excellent in all cases, rejection episodes have not been encountered except in a small percentage of animals, and the surviving recipients are still in excellent health 3-6 months after transplantation. The possiblity that clones of responding lymphocytes might be selectively killed by this agent was suggested from earlier experiments and prompted this study. If toxicity is not encountered in man cyclosporin A may prove valuable in preventing rejection of organ and bone-marrow allografts and might be useful in treating some leukaemias of lymphoid origin.
Similar articles
-
Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A.Lancet. 1978 Jun 3;1(8075):1183-5. doi: 10.1016/s0140-6736(78)90971-6. Lancet. 1978. PMID: 77948
-
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers.Lancet. 1979 Nov 17;2(8151):1033-6. doi: 10.1016/s0140-6736(79)92440-1. Lancet. 1979. PMID: 91781
-
Induction of specific tolerance in rabbits by kidney allografting and short periods of cyclosporin-A treatment.Lancet. 1979 Jul 21;2(8134):123-5. doi: 10.1016/s0140-6736(79)90005-9. Lancet. 1979. PMID: 88557
-
Tacrolimus: a further update of its use in the management of organ transplantation.Drugs. 2003;63(12):1247-97. doi: 10.2165/00003495-200363120-00006. Drugs. 2003. PMID: 12790696 Review.
-
Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.Drugs. 1993 Oct;46(4):746-94. doi: 10.2165/00003495-199346040-00009. Drugs. 1993. PMID: 7506654 Review.
Cited by
-
The history of cyclosporin A (Sandimmune) revisited: another point of view.Experientia. 1996 Jan 16;52(1):5-13. doi: 10.1007/BF01922409. Experientia. 1996. PMID: 8575558
-
Formation of insulin-secreting, Sertoli-enriched tissue constructs by microgravity coculture of isolated pig islets and rat Sertoli cells.In Vitro Cell Dev Biol Anim. 2001 Sep;37(8):490-8. doi: 10.1290/1071-2690(2001)037<0490:FOISSE>2.0.CO;2. In Vitro Cell Dev Biol Anim. 2001. PMID: 11669282
-
A new and clinically relevant murine model of solid-organ transplant aspergillosis.Dis Model Mech. 2013 May;6(3):643-51. doi: 10.1242/dmm.010330. Epub 2012 Dec 20. Dis Model Mech. 2013. PMID: 23264562 Free PMC article.
-
Cyclosporin A. Clinical pharmacology and therapeutic potential.Drugs. 1982 Oct;24(4):322-34. doi: 10.2165/00003495-198224040-00004. Drugs. 1982. PMID: 6754333 Review.
-
Steps in immunosuppression for renal transplantation.Kidney Int Suppl. 1983 May;(14):S-60-5. Kidney Int Suppl. 1983. PMID: 6348374 Free PMC article. Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources